Suzanne E. Sherman

1.7k total citations · 1 hit paper
8 papers, 1.5k citations indexed

About

Suzanne E. Sherman is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Suzanne E. Sherman has authored 8 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Suzanne E. Sherman's work include Metal complexes synthesis and properties (5 papers), DNA and Nucleic Acid Chemistry (4 papers) and Ferrocene Chemistry and Applications (3 papers). Suzanne E. Sherman is often cited by papers focused on Metal complexes synthesis and properties (5 papers), DNA and Nucleic Acid Chemistry (4 papers) and Ferrocene Chemistry and Applications (3 papers). Suzanne E. Sherman collaborates with scholars based in United States. Suzanne E. Sherman's co-authors include Stephen J. Lippard, Dan Gibson, Andrew H.‐J. Wang, Dan Gibson, Kenneth D. Karlin, A.H. Wang, Miquel Coll, Mark A. Greaney, Ola J. Martin and Liwen Wei and has published in prestigious journals such as Science, Chemical Reviews and Journal of the American Chemical Society.

In The Last Decade

Suzanne E. Sherman

8 papers receiving 1.4k citations

Hit Papers

Structural aspects of platinum anticancer drug interactio... 1987 2026 2000 2013 1987 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne E. Sherman United States 8 1.1k 819 639 220 181 8 1.5k
Jiřı́ Kozelka France 27 1.1k 1.0× 884 1.1× 792 1.2× 242 1.1× 232 1.3× 83 1.8k
Piedad del Socorro Murdoch United Kingdom 22 1.3k 1.3× 677 0.8× 1.0k 1.6× 297 1.4× 246 1.4× 33 1.9k
Patricia M. Takahara United States 5 752 0.7× 820 1.0× 433 0.7× 238 1.1× 344 1.9× 7 1.4k
Mauro Coluccia Italy 26 1.7k 1.6× 646 0.8× 1.3k 2.1× 258 1.2× 187 1.0× 52 2.2k
Oldřich Vrána Czechia 27 2.0k 1.8× 1.1k 1.4× 1.5k 2.3× 321 1.5× 204 1.1× 54 2.5k
Jeroen H. J. Den Hartog Netherlands 16 1.2k 1.1× 1.2k 1.5× 611 1.0× 152 0.7× 90 0.5× 19 1.6k
Christen M. Giandomenico United States 16 1.7k 1.6× 600 0.7× 1.5k 2.3× 389 1.8× 383 2.1× 19 2.4k
Daniel P. Bancroft United States 16 637 0.6× 416 0.5× 557 0.9× 159 0.7× 156 0.9× 24 1.1k
Jean-Pierre Macquet France 20 976 0.9× 699 0.9× 657 1.0× 250 1.1× 73 0.4× 37 1.3k
Seiji Komeda Japan 23 1.1k 1.1× 566 0.7× 983 1.5× 283 1.3× 126 0.7× 48 1.6k

Countries citing papers authored by Suzanne E. Sherman

Since Specialization
Citations

This map shows the geographic impact of Suzanne E. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Sherman more than expected).

Fields of papers citing papers by Suzanne E. Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne E. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Sherman. The network helps show where Suzanne E. Sherman may publish in the future.

Co-authorship network of co-authors of Suzanne E. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne E. Sherman. A scholar is included among the top collaborators of Suzanne E. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne E. Sherman. Suzanne E. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Scarpellini, Marciela, J. Gätjens, Ola J. Martin, et al.. (2008). Modeling the Resting State of Oxalate Oxidase and Oxalate Decarboxylase Enzymes. Inorganic Chemistry. 47(9). 3584–3593. 28 indexed citations
2.
Odom, Duncan T., et al.. (2000). Synthesis and characterization of magnesium and zinc complexes of 1,4,7-triazacyclononane-N-acetate. Potential models for the active site of RuBisCo. Inorganica Chimica Acta. 297(1-2). 404–410. 7 indexed citations
3.
Murray, H. H., Liwen Wei, Suzanne E. Sherman, et al.. (1995). Induced Internal Electron Transfer Chemistry in Rhenium Sulfide Systems. Inorganic Chemistry. 34(4). 841–853. 38 indexed citations
4.
Coll, Miquel, Suzanne E. Sherman, Dan Gibson, Stephen J. Lippard, & A.H. Wang. (1990). Molecular Structure of the Complex Formed Between the Anticancer Drug Cisplatin and d(pGpG): C2221Crystal Form. Journal of Biomolecular Structure and Dynamics. 8(2). 315–330. 40 indexed citations
5.
Sherman, Suzanne E., et al.. (1988). Crystal and molecular structure of cis-[Pt(NH3)2[d(pGpG)]], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA. Journal of the American Chemical Society. 110(22). 7368–7381. 210 indexed citations
6.
Sherman, Suzanne E. & Stephen J. Lippard. (1987). Structural aspects of platinum anticancer drug interactions with DNA. Chemical Reviews. 87(5). 1153–1181. 820 indexed citations breakdown →
7.
Sherman, Suzanne E., Dan Gibson, Andrew H.‐J. Wang, & Stephen J. Lippard. (1985). X-Ray Structure of the Major Adduct of the Anticancer Drug Cisplatin with DNA: cis -[Pt(NH 3 ) 2 {d(pGpG)}]. Science. 230(4724). 412–417. 337 indexed citations
8.
Karlin, Kenneth D. & Suzanne E. Sherman. (1982). Redox comparisons of pseudotetrahedral copper(I) complexes containing tripod ligands. Inorganica Chimica Acta. 65. L39–L40. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026